Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bevacizumab (avastin) (1 trial)
capecitabine (xeloda) (1 trial)
cisplatin (platinol) (1 trial)
docetaxel (taxotere) (1 trial)
fluorouracil (efudex) (2 trials)
irinotecan (Camptosar) (2 trials)
leucovorin (2 trials)
gemcitabine (gemzar) (1 trial)
paclitaxel (taxol) (1 trial)
pemetrexed (alimta) (1 trial)
Adenocarcinoma (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Colorectal Neoplasms (Phase 3)
Esophageal Neoplasms (Phase 3)
Lung Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (10 total)